Collins Cooper C.
Chief Strategic Officer at PERNIX THERAPEUTICS HOLDINGS, INC.; Director at TXMD
- Sold, on record
- $21.8M
- Dollars the filings state
- Form 4 sales
- 12
- Latest Apr 2, 2014
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- PERNIX THERAPEUTICS HOLDINGS, INC.Chief Strategic Officer
- TXMDTherapeuticsMD, Inc.Director
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- PERNIX THERAPEUTICS HOLDINGS, INC.4.6M shares
- TXMD2.6M shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale PERNIX THERAPEUTICS HOLDINGS, INC.Plan not statedNov 5 2013
Sold 90,000 shares at $2.00 ($180k)
Collins Cooper C., Chief Strategic Officer
Sold 1.4% of holdings ($13.1M position)6.5M shares leftFiling
- 2 Form 4 sale PERNIX THERAPEUTICS HOLDINGS, INC.Plan not statedDec 4 +29 days
Sold 52,548 shares at $2.44 ($128k)
Collins Cooper C., Chief Strategic Officer
Sold 0.8% of holdings ($15.7M position)6.4M shares left0.8x usual sizeFiling
- 3 Form 4 sale PERNIX THERAPEUTICS HOLDINGS, INC.Plan not statedDec 6 +2 days
Sold 37,452 shares at $2.31 ($87k)
Collins Cooper C., Chief Strategic Officer
Sold 0.6% of holdings ($14.8M position)6.4M shares left0.6x usual sizeFiling
- 4 Form 4 sale PERNIX THERAPEUTICS HOLDINGS, INC.Plan not statedJan 6 +31 days
Sold 62,038 shares at $2.35 ($146k)
Collins Cooper C., Chief Strategic Officer
Sold 1% of holdings ($14.9M position)6.3M shares left1.2x usual sizeFiling
- 5 Form 4 sale PERNIX THERAPEUTICS HOLDINGS, INC.Plan not statedJan 7 +1 day
Sold 27,962 shares at $2.20 ($62k)
Collins Cooper C., Chief Strategic Officer
Sold 0.4% of holdings ($13.9M position)6.3M shares left0.5x usual sizeFiling
- 6 Form 4 sale PERNIX THERAPEUTICS HOLDINGS, INC.Plan not statedFeb 5 +29 days
Sold 90,000 shares at $2.22 ($200k)
Collins Cooper C., Chief Strategic Officer
Sold 1.4% of holdings ($13.9M position)6.2M shares left1.7x usual sizeFiling
- 7 Form 4 sale PERNIX THERAPEUTICS HOLDINGS, INC.UnusualMar 4 +27 days
Sold 3.6M shares at $3.41 ($12.2M)
Collins Cooper C., Chief Strategic Officer
Sold 58.1% of holdings ($21M position)2.6M shares left62.7x usual sizeFiling
- 8 Form 4 sale PERNIX THERAPEUTICS HOLDINGS, INC.Plan not statedApr 2 +29 days
Sold 90,000 shares at $5.26 ($473k)
Collins Cooper C., Chief Strategic Officer
Sold 3.5% of holdings ($13.6M position)2.5M shares left1.5x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (12)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Apr 2, 2014 | PERNIX THERAPEUTICS HOLDINGS, INC. | Chief Strategic Officer | Form 4 sale | 90,000 | $473k | 3.5% | Plan not stated | SEC |
| Mar 4, 2014 | PERNIX THERAPEUTICS HOLDINGS, INC. | Chief Strategic Officer | Form 4 sale | 3.6M | $12.2M | 58.1% | Unusual | SEC |
| Feb 5, 2014 | PERNIX THERAPEUTICS HOLDINGS, INC. | Chief Strategic Officer | Form 4 sale | 90,000 | $200k | 1.4% | Plan not stated | SEC |
| Jan 7, 2014 | PERNIX THERAPEUTICS HOLDINGS, INC. | Chief Strategic Officer | Form 4 sale | 27,962 | $62k | 0.4% | Plan not stated | SEC |
| Jan 6, 2014 | PERNIX THERAPEUTICS HOLDINGS, INC. | Chief Strategic Officer | Form 4 sale | 62,038 | $146k | 1.0% | Plan not stated | SEC |
| Dec 6, 2013 | PERNIX THERAPEUTICS HOLDINGS, INC. | Chief Strategic Officer | Form 4 sale | 37,452 | $87k | 0.6% | Plan not stated | SEC |
| Dec 4, 2013 | PERNIX THERAPEUTICS HOLDINGS, INC. | Chief Strategic Officer | Form 4 sale | 52,548 | $128k | 0.8% | Plan not stated | SEC |
| Nov 5, 2013 | PERNIX THERAPEUTICS HOLDINGS, INC. | Chief Strategic Officer | Form 4 sale | 90,000 | $180k | 1.4% | Plan not stated | SEC |
| Oct 8, 2013 | PERNIX THERAPEUTICS HOLDINGS, INC. | Chief Strategic Officer | Form 4 sale | 23,364 | $58k | 0.4% | Plan not stated | SEC |
| Oct 3, 2013 | PERNIX THERAPEUTICS HOLDINGS, INC. | Chief Strategic Officer | Form 4 sale | 66,636 | $170k | 1.0% | Plan not stated | SEC |
| Jun 14, 2013 | TXMD | Director | Form 4 sale | 2.6M | $4.6M | 100.0% | Unusual | SEC |
| Jul 21, 2011 | PERNIX THERAPEUTICS HOLDINGS, INC. | President and CEO | Form 4 sale | 498,429 | $3.5M | 5.3% | Plan not stated | SEC |